James W. Larrick
59Patents
13h-index
51Co-inventors
87Inventor score
Filing activity: Apr 26, 1984 → Sep 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6114149A | Amplification of mixed sequence nucleic acid fragments | Chemistry; Metallurgy | 139 | Expired |
| US6717012B2 | Antioxidant nitroxides and nitrones as therapeutic agents | Chemistry; Metallurgy | 28 | Expired |
| US6444702B1 | Aminoadamantane derivatives as therapeutic agents | Chemistry; Metallurgy | 28 | Expired |
| US8889140B2 | Compositions and methods for tissue repair | Chemistry; Metallurgy | 26 | Active |
| US6852889B2 | Antioxidant nitroxides and nitrones as therapeutic agents | Chemistry; Metallurgy | 24 | Expired |
| US9663782B2 | Methods and compositions for producing double allele knock outs | Chemistry; Metallurgy | 24 | Active |
| US4677070A | Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5843937A | DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents | Chemistry; Metallurgy | 24 | Expired |
| US6620845B2 | Aminoadamantane derivatives as therapeutic agents | Chemistry; Metallurgy | 23 | Expired |
| US9198898B2 | Use of NK-1 receptor antagonists in pruritus | Emerging Cross-Sectional Technologies | 20 | Active |
| US4624921A | Human lymphoblastold cell line and hybridomas derived therefrom | Emerging Cross-Sectional Technologies | 19 | Expired |
| US8906951B1 | Use of NK-1 receptor antagonists in pruritus | Emerging Cross-Sectional Technologies | 16 | Active |
| US5670151A | Method for controlling hyperproliferative diseases | Human Necessities | 15 | Expired |
| US4684623A | Use of tumor necrosis factor as a weight regulator | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5001065A | Human cell line and triomas, antibodies, and transformants derived therefrom | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5567611A | Multifunctional M-CSF proteins and genes encoding therefor | Chemistry; Metallurgy | 12 | Expired |
| US7951378B2 | Immunoadhesin comprising a chimeric ICAM-1 molecule produced in a plant | Chemistry; Metallurgy | 11 | Expired |
| US9381188B2 | Use of NK-1 receptor antagonists in pruritus | Emerging Cross-Sectional Technologies | 11 | Active |
| US5618675A | Methods and compositions for detecting lipopolysaccharides using CAP18 fragments | Human Necessities | 10 | Expired |
| US5605826A | 24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis | Human Necessities | 8 | Expired |
| US9486439B2 | Use of NK-1 receptor antagonist serlopitant in pruritus | Emerging Cross-Sectional Technologies | 7 | Active |
| US9737507B2 | Use of NK-1 receptor antagonist serlopitant in pruritus | Emerging Cross-Sectional Technologies | 7 | Active |
| US9737508B2 | Use of NK-1 receptor antagonists in pruritus | Emerging Cross-Sectional Technologies | 7 | Active |
| US9474741B2 | Use of NK-1 receptor antagonists in pruritus | Emerging Cross-Sectional Technologies | 7 | Active |
| US6291431A | Methods and compositions for the treatment and prevention of Staphylococcal infections | Human Necessities | 6 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.